STEPAN CO SCL

Healthcare SIC 2840 - Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing › Soap and Cleaning Compound Manufacturing derived NYSE

Last close 63.91 2026-10-23
Market cap $1.45B 2026-06-30 share count
52-week range 41.82 - 68.00

Valuation FY2025 figures against the last close

P/S0.6x
P/E31.2x
P/FCF57.3x
EV/EBITDA9.5x
Dividend yield2.4%
Diluted EPS2.05

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.33B$2.18B$2.33B$2.77B$2.35B$1.87B$1.86B$1.99B$1.93B$1.77B
Cost of revenue $2.06B$1.91B$2.05B$2.35B$1.95B$1.49B$1.52B$1.65B$1.58B$1.43B
Gross profit $269.9M$272.2M$277.6M$427.1M$395.8M$383.6M$339.7M$339.3M$346.2M$339.3M
R&D $34.8M$33.5M$35.7M$40.9M$38.8M$36.0M$34.1M$33.5M$33.2M$34.9M
SG&A $90.8M$98.3M$93.2M$102.2M$92.9M$87.4M$82.6M$79.2M$75.6M$74.9M
Total operating expenses $201.0M$201.7M$205.0M$218.4M$221.7M$210.9M$209.7M$187.5M$188.3M$204.4M
Operating income $78.5M$70.5M$58.6M$207.3M$170.8M$171.5M$127.3M$149.3M$154.8M$127.8M
Pre-tax income $59.9M$60.4M$48.4M$188.7M$172.5M$171.1M$125.9M$137.8M$146.9M$113.8M
Income tax $13.0M$10.1M$8.2M$41.5M$34.6M$43.4M$22.8M$26.7M$46.1M$27.6M
Net income $46.9M$50.4M$40.2M$147.2M$137.8M$126.8M$103.1M$111.1M$100.8M$86.2M
EPS, basic 2.052.211.776.466.015.524.474.834.393.78
EPS, diluted 2.052.201.756.385.925.454.424.764.313.73
Shares, diluted (wtd. avg.) 22.9M22.9M22.9M23.1M23.3M23.3M23.3M23.3M23.4M23.1M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $132.7M$99.7M$129.8M$173.8M$159.2M$349.9M$315.4M$300.2M$298.9M$225.7M
Receivables $388.0M$388.0M$422.1M$436.9M$419.5M$301.3M$276.8M$280.0M$293.5M$263.4M
Inventory $298.8M$288.7M$265.6M$402.5M$305.5M$218.8M$203.6M$231.5M$172.7M$173.7M
Total current assets $859.0M$810.4M$851.9M$1.04B$913.4M$905.7M$818.8M$833.9M$788.7M$685.5M
Property, plant and equipment $1.22B$1.20B$1.21B$1.07B$850.6M$682.7M$639.3M$608.9M$598.4M$582.7M
Goodwill $92.6M$91.4M$97.4M$95.9M$97.2M$28.0M$26.1M$23.0M$25.1M$25.3M
Other intangibles $39.5M$42.7M$52.6M$58.0M$60.8M$24.1M$15.4M$14.2M$18.5M$22.3M
Total assets $2.36B$2.30B$2.36B$2.43B$2.07B$1.75B$1.58B$1.51B$1.50B$1.35B
Accounts payable $261.7M$258.8M$233.0M$375.7M$323.4M$236.8M$194.3M$206.0M$205.0M$158.3M
Short-term debt $285.7M$292.8M$252.9M$132.1M$40.7M$37.9M$23.6M$37.1M$22.5M$28.2M
Total current liabilities $666.5M$669.0M$607.9M$670.6M$500.5M$416.6M$339.1M$338.6M$320.3M$297.3M
Long-term debt $341.0M$332.6M$401.2M$455.0M$322.9M$160.8M$198.5M$239.0M$268.3M$288.9M
Retained earnings $1.29B$1.27B$1.26B$1.25B$1.13B$1.02B$922.5M$837.1M$721.7M$649.1M
Total equity $1.24B$1.17B$1.22B$1.17B$1.07B$988.4M$892.5M$808.2M$766.2M$652.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $147.9M$162.1M$174.9M$160.8M$72.1M$235.2M$218.4M$171.1M$198.9M$212.2M
Depreciation and amortisation $126.0M$112.2M$105.3M$94.7M$90.9M$81.9M$78.7M$81.1M$79.0M$75.0M
Stock-based compensation $6.0M$5.3M$5.7M$13.9M$11.7M$10.1M$8.9M$6.8M$7.2M$12.6M
Capital expenditure $122.5M$122.8M$260.3M$301.6M$194.5M$125.8M$105.6M$86.6M$78.6M$103.1M
Investing cash flow -$89.0M-$116.9M-$258.7M-$308.1M-$376.8M-$139.0M-$112.7M-$107.8M-$82.7M-$130.5M
Financing cash flow -$35.4M-$64.5M$33.3M$166.2M$117.3M-$64.9M-$90.5M-$51.6M-$50.5M-$29.8M
Dividends paid $35.0M$34.0M$32.9M$30.6M$28.1M$25.4M$23.1M$20.9M$18.9M$17.3M
Buybacks ———$24.9M$17.0M$15.3M$13.2M$15.5M$6.0M$2.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-074976.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 1B 2B 3B Revenue, FY2016: 1.8B Gross profit, FY2016: 339.3M Net income, FY2016: 86.2M Revenue, FY2017: 1.9B Gross profit, FY2017: 346.2M Net income, FY2017: 100.8M Revenue, FY2018: 2B Gross profit, FY2018: 339.3M Net income, FY2018: 111.1M Revenue, FY2019: 1.9B Gross profit, FY2019: 339.7M Net income, FY2019: 103.1M Revenue, FY2020: 1.9B Gross profit, FY2020: 383.6M Net income, FY2020: 126.8M Revenue, FY2021: 2.3B Gross profit, FY2021: 395.8M Net income, FY2021: 137.8M Revenue, FY2022: 2.8B Gross profit, FY2022: 427.1M Net income, FY2022: 147.2M Revenue, FY2023: 2.3B Gross profit, FY2023: 277.6M Net income, FY2023: 40.2M Revenue, FY2024: 2.2B Gross profit, FY2024: 272.2M Net income, FY2024: 50.4M Revenue, FY2025: 2.3B Gross profit, FY2025: 269.9M Net income, FY2025: 46.9M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.77B $1.93B $1.99B $1.86B $1.87B $2.35B $2.77B $2.33B $2.18B $2.33B
Gross profit $339.3M $346.2M $339.3M $339.7M $383.6M $395.8M $427.1M $277.6M $272.2M $269.9M
Net income $86.2M $100.8M $111.1M $103.1M $126.8M $137.8M $147.2M $40.2M $50.4M $46.9M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Restructuring or exit costs A restructuring: layoffs, a plant closure, a business being wound down. Item 2.05
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Restructuring or exit costs Item 2.05
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2840

TickerCompanyMarket capP/ERevenue growth
PG PROCTER & GAMBLE Co $374.28B 24.3x 3.3%
ECL ECOLAB INC. $80.88B 39.6x 2.2%
CHD CHURCH & DWIGHT CO INC /DE/ $24.95B 34.8x 1.6%
UL UNILEVER PLC — — —
WNW Meiwu Technology Co Ltd — — 4,368.0%
BYAH Park Ha Biological Technology Co., Ltd. — — 6.0%